Endocrinology, Vol 110, 575-581, Copyright © 1982 by Endocrine Society

ARTICLES

Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication- stimulating activity RRA after acid-ethanol extraction

WH Daughaday, KA Parker, S Borowsky, B Trivedi and M Kapadia

Previous measurements of somatomedins (Sms) and insulin-like growth factors (IGFs) in maternal and fetal serum have yielded contradictory results. We have, therefore, measured maternal, fetal, and neonatal rat serum with two highly specific assays: 1) IGF-I/Sm-C RiA and 2) a highly specific IGF-II/rat placental membrane radioreceptor assay (RRA). In addition, we have made measurements with a less specific multiplication-stimulating activity (MSA)-rat placental membrane RRA. To avoid possible serious artifacts created by Sm-binding proteins, preliminary acid-ethanol extraction of serum was performed. Results are expressed in terms of a reference human serum with an assigned potency of 1 U/ml. Maternal RIA IGF-I fluctuated between 1.1-1.4 U/ml from the 17th day of pregnancy to the 25th day after delivery (nonpregnant rat serum pool, 1.25 +/- 0.22 U/ml). On day 21 of gestation, fetal serum radioimmunoassayable IGF-I was 1.03 +/- 0.03 U/ml. After birth, radioimmunoassayable IGF-I fell and reached .19 +/- 0.03 U/ml at 18 days of age, but rose to 0.71 +/- 0.04 U/ml at 25 days of age. At term, maternal radioreceptor assayable IGF-II was 2.18 +/- 0.27 U/ml (nonpregnant female pool, 1.4 +/- 0.12). By the 25th postpartum day, radioreceptor assayable IGF-II was 1.39 +/- 0.12 U/ml. Radioreceptor assayable IGF-II in fetal serum on day 19 was 3.26 +/- 0.48 U/ml and rose to 5.37 +/- 0.66 U/ml on the day of delivery. A further rise to 8.92 +/- 1.03 occurred on day 5. A subsequent fall to 2.41 +/- 0.05 U/ml was observed on day 25. The patterns of results of the MSA RRA in fetal and neonatal rat serum were similar to that obtained with the IGF- II RRA. We now conclude that radioimmunoassayable IGF-I is present in higher concentrations than previously reported in term fetal rat serum and that radioreceptor assayable IGF-II is selectively elevated in rat fetal and neonatal life and may have unique metabolic and growth- promoting significance.U

This article has been cited by other articles:

				E. Marzetti, L. Groban, S. E. Wohlgemuth, H. A. Lees, M. Lin, H. Jobe, S. Giovannini, C. Leeuwenburgh, and C. S. Carter Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R558 - R567. [Abstract] [Full Text] [PDF]

				L. Groban, N. A. Pailes, C. D. L. Bennett, C. S. Carter, M. C. Chappell, D. W. Kitzman, and W. E. Sonntag Growth Hormone Replacement Attenuates Diastolic Dysfunction and Cardiac Angiotensin II Expression in Senescent Rats J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2006; 61(1): 28 - 35. [Abstract] [Full Text] [PDF]

				T. Yonezawa, K. Mogi, J. Y. Li, R. Sako, K. Yamanouchi, and M. Nishihara Modulation of Growth Hormone Pulsatility by Sex Steroids in Female Goats Endocrinology, June 1, 2005; 146(6): 2736 - 2743. [Abstract] [Full Text] [PDF]

				S. H. Lee and K. L. Hossner Coordinate regulation of ovine adipose tissue gene expression by propionate J Anim Sci, November 1, 2002; 80(11): 2840 - 2849. [Abstract] [Full Text] [PDF]

				P. Menuelle, S. Babajko, and C. Plas Insulin-Like Growth Factor (IGF) Binding Proteins Modulate the Glucocorticoid-Dependent Biological Effects of IGF-II in Cultured Fetal Rat Hepatocytes Endocrinology, May 1, 1999; 140(5): 2232 - 2240. [Abstract] [Full Text]

				C. Y. Cheung, D. D. Johnson, and V. Reyes Ontogeny of Insulin-Like Growth Factor-I and -II Gene Expression in Ovine Fetal Heart Reproductive Sciences, November 1, 1996; 3(6): 309 - 315. [Abstract] [PDF]

				M. Oldstone, P Southern, M Rodriquez, and P Lampert Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes Science, June 29, 1984; 224(4656): 1440 - 1443. [Abstract] [PDF]